402 related articles for article (PubMed ID: 10673787)
21. Oral hairy leukoplakia in 71 HIV-seropositive patients: clinical symptoms, relation to immunologic status, and prognostic significance.
Husak R; Garbe C; Orfanos CE
J Am Acad Dermatol; 1996 Dec; 35(6):928-34. PubMed ID: 8959952
[TBL] [Abstract][Full Text] [Related]
22. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
Enssle KH; Fleischer B
Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of Epstein-Barr virus and human papillomavirus in oral mucosa of HIV-infected patients.
Adler-Storthz K; Ficarra G; Woods KV; Gaglioti D; DiPietro M; Shillitoe EJ
J Oral Pathol Med; 1992 Apr; 21(4):164-70. PubMed ID: 1318379
[TBL] [Abstract][Full Text] [Related]
24. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
[TBL] [Abstract][Full Text] [Related]
25. Human immunodeficiency virus type 1 (HIV-1)--and Epstein-Barr virus--specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1--infected persons.
Geretti AM; Dings ME; van Els CA; van Baalen CA; Wijnholds FJ; Borleffs JC; Osterhaus AD
J Infect Dis; 1996 Jul; 174(1):34-45. PubMed ID: 8656011
[TBL] [Abstract][Full Text] [Related]
26. Ex vivo generation of effective Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes from the peripheral blood of immunocompetent Epstein Barr virus-seronegative individuals.
Metes D; Storkus W; Zeevi A; Patterson K; Logar A; Rowe D; Nalesnik MA; Fung JJ; Rao AS
Transplantation; 2000 Nov; 70(10):1507-15. PubMed ID: 11118098
[TBL] [Abstract][Full Text] [Related]
27. A simple and rapid technique for the detection of Epstein-Barr virus DNA in HIV-associated oral hairy leukoplakia biopsies.
Mabruk MJ; Antonio M; Flint SR; Coleman DC; Toner M; Kay E; Leader M; Atkins GJ
J Oral Pathol Med; 2000 Mar; 29(3):118-22. PubMed ID: 10738938
[TBL] [Abstract][Full Text] [Related]
28. Oral hairy leukoplakia: clinicopathologic features, pathogenesis, diagnosis, and clinical significance.
Triantos D; Porter SR; Scully C; Teo CG
Clin Infect Dis; 1997 Dec; 25(6):1392-6. PubMed ID: 9431384
[TBL] [Abstract][Full Text] [Related]
29. Progressive loss of IL-2-expandable HIV-1-specific cytotoxic T lymphocytes during asymptomatic HIV infection.
Jin X; Wills M; Sissons JG; Carmichael A
Eur J Immunol; 1998 Nov; 28(11):3564-76. PubMed ID: 9842899
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of oral hairy leukoplakia in 120 pediatric patients infected with HIV-1.
Dias EP; Israel MS; Silva Junior A; Maciel VA; Gagliardi JP; Oliveira RH
Braz Oral Res; 2006; 20(2):103-7. PubMed ID: 16878201
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus infection and expression in oral lesions.
Raab-Traub N; Webster-Cyriaque J
Oral Dis; 1997 May; 3 Suppl 1():S164-70. PubMed ID: 9456682
[TBL] [Abstract][Full Text] [Related]
32. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D
Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575
[TBL] [Abstract][Full Text] [Related]
33. Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients.
Ammatuna P; Campisi G; Giovannelli L; Giambelluca D; Alaimo C; Mancuso S; Margiotta V
Oral Dis; 2001 Jan; 7(1):34-40. PubMed ID: 11354920
[TBL] [Abstract][Full Text] [Related]
34. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
[TBL] [Abstract][Full Text] [Related]
35. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.
Khanna R; Burrows SR; Nicholls J; Poulsen LM
Eur J Immunol; 1998 Feb; 28(2):451-8. PubMed ID: 9521052
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus (EBV) DNA in saliva and EBV serology of HIV-1-infected persons with and without hairy leukoplakia.
Lucht E; Biberfeld P; Linde A
J Infect; 1995 Nov; 31(3):189-94. PubMed ID: 8586837
[TBL] [Abstract][Full Text] [Related]
37. [Oral hairy leukoplakia induced by topical steroids].
Vigarios E; Fricain JC; Projetti F; Boulanger M; Sibaud V
Ann Dermatol Venereol; 2015 Oct; 142(10):572-6. PubMed ID: 26362131
[TBL] [Abstract][Full Text] [Related]
38. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
[TBL] [Abstract][Full Text] [Related]
39. Oral Hairy Leukoplakia in Patients With No Evidence of Immunosuppression: A Case Series and Review of the Literature.
Darling MR; Alkhasawneh M; Mascarenhas W; Chirila A; Copete M
J Can Dent Assoc; 2018 May; 84():i4. PubMed ID: 31199724
[TBL] [Abstract][Full Text] [Related]
40. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men.
Rinaldo CR; Beltz LA; Huang XL; Gupta P; Fan Z; Torpey DJ
AIDS Res Hum Retroviruses; 1995 Apr; 11(4):481-9. PubMed ID: 7632463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
